ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,490 | -84.9% | 26,653 | -76.4% | 0.00% | – |
| Q2 2023 | $561,128 | +88.1% | 112,903 | +86.9% | 0.00% | – |
| Q1 2023 | $298,381 | +370.0% | 60,401 | +498.4% | 0.00% | – |
| Q4 2022 | $63,491 | -96.4% | 10,094 | -93.9% | 0.00% | -100.0% |
| Q3 2022 | $1,782,000 | +85.4% | 165,007 | +95.7% | 0.00% | – |
| Q2 2022 | $961,000 | +76.0% | 84,301 | +40.8% | 0.00% | – |
| Q1 2022 | $546,000 | -72.8% | 59,865 | -55.4% | 0.00% | – |
| Q4 2021 | $2,004,000 | +133.6% | 134,313 | +302.7% | 0.00% | – |
| Q3 2021 | $858,000 | +86.9% | 33,354 | +89.5% | 0.00% | – |
| Q2 2021 | $459,000 | +9.3% | 17,600 | +48.0% | 0.00% | – |
| Q1 2021 | $420,000 | -44.2% | 11,895 | -60.2% | 0.00% | – |
| Q4 2020 | $753,000 | -33.4% | 29,858 | -0.4% | 0.00% | -100.0% |
| Q3 2020 | $1,130,000 | -16.0% | 29,977 | -4.5% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | +80.8% | 31,405 | +15.1% | 0.00% | 0.0% |
| Q3 2019 | $744,000 | – | 27,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |